These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32737715)

  • 1. Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors.
    Aphivatanasiri C; Li J; Chan R; Jamidi SK; Tsang JY; Poon IK; Shao Y; Tong J; To KF; Chan SK; Tam F; Cheung SY; Shea KH; Tse GM
    Breast Cancer Res Treat; 2020 Nov; 184(1):11-21. PubMed ID: 32737715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sry-related high-mobility-group/HMG box 10 (SOX10) as a sensitive marker for triple-negative breast cancer.
    Jamidi SK; Hu J; Aphivatanasiri C; Tsang JY; Poon IK; Li JJ; Chan SK; Cheung SY; Tse GM
    Histopathology; 2020 Dec; 77(6):936-948. PubMed ID: 32304249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of GATA3, SOX-10, and PAX8 in a Comprehensive Panel to Diagnose Breast Cancer Metastases.
    Na K; Woo HY; DO SI; Kim SW
    In Vivo; 2022; 36(1):473-481. PubMed ID: 34972751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma.
    Laurent E; Begueret H; Bonhomme B; Veillon R; Thumerel M; Velasco V; Brouste V; Hoppe S; Fournier M; Grellety T; MacGrogan G
    Am J Surg Pathol; 2019 Mar; 43(3):293-302. PubMed ID: 30628926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of SOX10 and GATA3 in mammary carcinoma.
    Qazi MS; McGregor SM
    Pathol Res Pract; 2020 Feb; 216(2):152801. PubMed ID: 31924335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma.
    Yoon EC; Wang G; Parkinson B; Huo L; Peng Y; Wang J; Salisbury T; Wu Y; Chen H; Albarracin CT; Resetkova E; Middleton LP; Krishnamurthy S; Gan Q; Sun H; Huang X; Shen T; Chen W; Parwani AV; Sahin AA; Li Z; Ding Q
    Hum Pathol; 2022 Jul; 125():97-107. PubMed ID: 35413381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.
    Sangoi AR; Shrestha B; Yang G; Mego O; Beck AH
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):229-37. PubMed ID: 25906123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPS1 is a promising marker for all subtypes of breast cancer.
    Lui JW; Tsang JY; Li J; Ko CW; Tam F; Loong TC; Tse GM
    Histopathology; 2024 Apr; 84(5):822-836. PubMed ID: 38173281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative expression of TRPS1, GATA3, SOX10, mammaglobin, and GCDFP-15 in effusion specimens with breast carcinoma.
    Bradt A; Jing X; Smola BS; Lew M
    Diagn Cytopathol; 2023 Nov; 51(11):665-673. PubMed ID: 37461248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer.
    Ni YB; Tsang JYS; Shao MM; Chan SK; Cheung SY; Tong J; To KF; Tse GM
    Breast Cancer Res Treat; 2018 May; 169(1):25-32. PubMed ID: 29340880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of SOX10 and GATA3 in breast cancer and their significance].
    Liu JL; Chen DS; Cheng ZQ; Hu JT
    Zhonghua Bing Li Xue Za Zhi; 2022 Jun; 51(6):536-541. PubMed ID: 35673726
    [No Abstract]   [Full Text] [Related]  

  • 12. GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors.
    Yang Y; Lu S; Zeng W; Xie S; Xiao S
    Ann Diagn Pathol; 2017 Feb; 26():1-5. PubMed ID: 28038704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of GATA3 and SOX10 is useful for the diagnosis of metastatic triple-negative breast cancer.
    Tozbikian GH; Zynger DL
    Hum Pathol; 2019 Mar; 85():221-227. PubMed ID: 30468800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of combined application of GATA3, SOX10 and p16 in triple negative breast carcinomas].
    Zhang DM; Zhai CJ; Feng XD; Wang CZ; Qiu JF; Wei JG
    Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(10):735-740. PubMed ID: 35280018
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical Profile of Triple-Negative Breast Cancers: SOX10 and AR Dual Negative Tumors Have Worse Outcomes.
    Rammal R; Goel K; Motanagh SA; Carter GJ; Clark BZ; Fine JL; Harinath L; Villatoro TM; Yu J; Bhargava R
    Mod Pathol; 2024 Jul; 37(7):100517. PubMed ID: 38763422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin.
    Du T; Pan L; Zheng C; Chen K; Yang Y; Chen J; Chao X; Li M; Lu J; Luo R; Zhang J; Wu Y; He J; Jiang D; Sun P
    Breast Cancer Res; 2022 Oct; 24(1):70. PubMed ID: 36284362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours.
    Wu Y; Chen F; Pan L; Chao X; Li M; Luo R; Chen K; Zheng C; Du T; He J; Sun P
    Pathology; 2024 Jun; 56(4):516-527. PubMed ID: 38570266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Added Value of SOX10 Immunohistochemistry to Other Breast Markers in Identifying Cytokeratin 5-Positive Triple Negative Breast Cancers as of Mammary Origin.
    Sejben A; Vörös A; Golan A; Zombori T; Cserni G
    Pathobiology; 2021; 88(3):228-233. PubMed ID: 33567441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological, immunohistochemical and molecular correlation of neural crest transcription factor SOX10 expression in triple-negative breast carcinoma.
    Harbhajanka A; Chahar S; Miskimen K; Silverman P; Harris L; Williams N; Varadan V; Gilmore H
    Hum Pathol; 2018 Oct; 80():163-169. PubMed ID: 29894722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive analysis of GATA3 expression in carcinomas of various origins with emphasis on lung carcinomas.
    Bota EC; Koumoundourou D; Ravazoula P; Zolota V; Psachoulia C; Kardari M; Karampitsakos T; Tzouvelekis A; Tzelepi V; Sampsonas F
    Monaldi Arch Chest Dis; 2023 Aug; 94(2):. PubMed ID: 37667882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.